FONAR CORP (FONR)
2025-03-31 | 2024-09-30 | |||
|---|---|---|---|---|
| Total revenues net | 27,165 | 24,960 | ||
| Selling, general and administrative expenses | 7,991 | 5,130 | ||
| Research and development | 441 | 307 | ||
| Costs related to patient fee revenue | 4,901 | 4,646 | ||
| Costs related to service and repair fees related parties | 58 | 67 | ||
| Costs related to service and repair fees | 1,182 | 1,091 | ||
| Costs related to product sales | 319 | 221 | ||
| Costs related to management and other fees related medical practices | 1,714 | 1,573 | ||
| Costs related to management and other fees | 6,897 | 7,319 | ||
| Total costs and expenses | 23,503 | 20,354 | ||
| Income from operations | 3,662 | 4,606 | ||
| Investment income related party | 13 | 13 | ||
| Interest expense | 7 | 8 | ||
| Investment income | 463 | 639 | ||
| Other income | -1 | -1 | ||
| Income before provision for income taxes and noncontrolling interests | 4,130 | 5,249 | ||
| Provision for income taxes | 1,006 | 1,249 | ||
| Consolidated net income | 3,124 | - | ||
| Net income noncontrolling interests | 618 | 865 | ||
| Net income (loss), including portion attributable to noncontrolling interest | - | 4,000 | ||
| Net income attributable to fonar | 2,506 | 3,135 | ||
| Basic eps | 0.38 | 0.47 | ||
| Diluted eps | 0.37 | 0.46 | ||
| Basic average shares | 6,865,000 | 6,304,000 | ||
| Diluted average shares | 6,296,000 | 6,432,000 | ||